Neural Therapeutics Inc. (CSE:NURL)

Neural Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is August - July.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Debt / Equity Ratio	-0.03	-0.56	-0.53	-
Quick Ratio	1.92	0.31	0.72	0.91
Current Ratio	1.92	0.31	0.74	0.98
Return on Assets (ROA)	-101.99%	-183.08%	-186.98%	-
Buyback Yield / Dilution	-31.99%	-58.39%	-7.98%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.